These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 904673)

  • 21. Yellow nails as an adverse reaction to the topical use of 5-fluorouracil for the treatment of nail psoriasis.
    Fiallo P
    J Dermatolog Treat; 2009; 20(5):299-301. PubMed ID: 19363737
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Allergic reaction to 5-fluorouracil infusion.
    Sridhar KS
    Cancer; 1986 Aug; 58(4):862-4. PubMed ID: 3719553
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of topical fluorouracil on normal skin.
    Zelickson AS; Mottaz J; Weiss LW
    Arch Dermatol; 1975 Oct; 111(10):1301-6. PubMed ID: 1190801
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hospitalization for 5-FU toxicity in metastatic colorectal cancer: incidence and cost.
    Oster G
    Oncology (Williston Park); 1999 Jul; 13(7 Suppl 3):41. PubMed ID: 10442358
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of keloid scars with intralesional triamcinolone and 5-fluorouracil injections - a randomized controlled trial.
    Hietanen KE; Järvinen TA; Huhtala H; Tolonen TT; Kuokkanen HO; Kaartinen IS
    J Plast Reconstr Aesthet Surg; 2019 Jan; 72(1):4-11. PubMed ID: 30448246
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cutaneous recall reactions with systemic fluorouracil.
    Kirkup ME; Narayan S; Kennedy CT
    Dermatology; 2003; 206(2):175-6. PubMed ID: 12592090
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Actikerall™ (5-Fluorouracil 0.5% and Salicylic Acid 10%) Topical Solution for Patient-directed Treatment of Actinic Keratoses.
    Nguyen HP; Rivers JK
    Skin Therapy Lett; 2016 May; 21(3):1-3. PubMed ID: 27223248
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selective inflammatory effect of systemic fluorouracil in actinic keratosis.
    Nabai H; Mohindra R; Mehregan D
    Cutis; 1999 Jul; 64(1):43-4. PubMed ID: 10431671
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Erythroplasia of Queyrat: repor. of a patient successfully treated with topical 5-fluorouracil.
    Lewis RJ; Bendl BJ
    Can Med Assoc J; 1971 Jan; 104(2):148-9. PubMed ID: 5539006
    [No Abstract]   [Full Text] [Related]  

  • 30. Fluorouracil-Loaded Gold Nanoparticles for the Treatment of Skin Cancer: Development, in Vitro Characterization, and in Vivo Evaluation in a Mouse Skin Cancer Xenograft Model.
    Safwat MA; Soliman GM; Sayed D; Attia MA
    Mol Pharm; 2018 Jun; 15(6):2194-2205. PubMed ID: 29701979
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of lip keratoses (actinic cheilitis) with topical fluorouracil.
    Epstein E
    Arch Dermatol; 1977 Jul; 113(7):906-8. PubMed ID: 879810
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Basic pharmacology of topical imiquimod, 5-fluorouracil, and diclofenac for the dermatologic surgeon.
    Desai T; Chen CL; Desai A; Kirby W
    Dermatol Surg; 2012 Jan; 38(1):97-103. PubMed ID: 22092926
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Topical chemotherapy of recurrent respiratory papillomatosis. A preliminary report.
    Smith HG; Healy GB; Vaughan CW; Strong MS
    Ann Otol Rhinol Laryngol; 1980; 89(5 Pt 1):472-8. PubMed ID: 7436255
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Letter: Treatment of condyloma acuminata with 5 per cent. 5-fluorouracil (5-FU) cream.
    Haye KR
    Br J Vener Dis; 1974 Dec; 50(6):466. PubMed ID: 4447868
    [No Abstract]   [Full Text] [Related]  

  • 35. Cicatricial ectropion: a complication of topical 5-fluorouracil.
    Nikkhah D; Abood A; Watt D
    J Plast Reconstr Aesthet Surg; 2012 Jan; 65(1):e9-10. PubMed ID: 21872544
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Contact sensitivity to budesonide in a child.
    Auricchio L; Nino M; Suppa F
    Contact Dermatitis; 2000 Jun; 42(6):359. PubMed ID: 10871107
    [No Abstract]   [Full Text] [Related]  

  • 37. Bioavailability of subcutaneous 5-fluorouracil: a case report.
    Eatock MM; Carlin W; Dunlop DJ; Soukop M; Watson DG
    Cancer Chemother Pharmacol; 1996; 38(1):110-2. PubMed ID: 8603444
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Studies on the allergenicity of 5-fluorouracil.
    Leyden JJ; Kligman AM
    J Dermatol Surg Oncol; 1977; 3(5):518-9. PubMed ID: 925250
    [No Abstract]   [Full Text] [Related]  

  • 39. Transdermal delivery of 5-fluorouracil through skin of hairless mice and humans in vitro: a comparison of the effect of formulations and a prodrug.
    Sherertz EF; Sloan KB; McTiernan RG
    Arch Dermatol Res; 1990; 282(7):463-8. PubMed ID: 2078050
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effect of 5-fluorouracil ointment on keratotic lesions and healthy skin].
    Czernielewski A; Karpińska A
    Przegl Dermatol; 1973; 60(1):57-61. PubMed ID: 4789829
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.